AG
CNMD icon

Aperio Group’s CONMED CNMD Stock Holding History

Aperio Group’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$838K Buy
7,482
+297
+4% +$28.1K ﹤0.01% 1691
2020
Q3 		$565K Sell
7,185
-12
-0.2% -$979 ﹤0.01% 1748
2020
Q2 		$518K Sell
7,197
-1,058
-13% -$73.6K ﹤0.01% 1755
2020
Q1 		$473K Sell
8,255
-790
-9% -$72.9K ﹤0.01% 1679
2019
Q4 		$1.01M Buy
9,045
+584
+7% +$62.2K ﹤0.01% 1430
2019
Q3 		$814K Buy
8,461
+896
+12% +$84.1K ﹤0.01% 1503
2019
Q2 		$647K Buy
7,565
+108
+1% +$8.88K ﹤0.01% 1638
2019
Q1 		$620K Buy
7,457
+1,379
+23% +$100K ﹤0.01% 1620
2018
Q4 		$390K Buy
6,078
+543
+10% +$37.2K ﹤0.01% 1827
2018
Q3 		$438K Buy
5,535
+433
+8% +$33.5K ﹤0.01% 1834
2018
Q2 		$373K Buy
5,102
+166
+3% +$11.3K ﹤0.01% 1901
2018
Q1 		$313K Buy
4,936
+100
+2% +$5.97K ﹤0.01% 1938
2017
Q4 		$246K Sell
4,836
-69
-1% -$3.59K ﹤0.01% 2056
2017
Q3 		$257K Sell
4,905
-129
-3% -$6.48K ﹤0.01% 2006
2017
Q2 		$256K Buy
5,034
+487
+11% +$24.1K ﹤0.01% 1976
2017
Q1 		$202K Sell
4,547
-2,462
-35% -$106K ﹤0.01% 2034
2016
Q4 		$310K Sell
7,009
-106
-1% -$4.5K ﹤0.01% 1777
2016
Q3 		$285K Buy
7,115
+1,778
+33% +$75.5K ﹤0.01% 1741
2016
Q2 		$255K Sell
5,337
-737
-12% -$31.2K ﹤0.01% 1731
2016
Q1 		$255K Buy
+6,074
New +$238K ﹤0.01% 1741
2015
Q3 		– Sell
-3,680
Closed -$214K – 1950
2015
Q2 		$214K Buy
+3,680
New +$198K ﹤0.01% 1821

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aperio Group's CNMD Position: Q4 2020 in Review

Aperio Group increased its CONMED (CNMD) stake by 4.1% in Q4 2020, buying an estimated $28.1K and bringing the position to 7,482 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Aperio Group first reported a position in CNMD in Q2 2015 and has held it in 21 quarters since. The position peaked at $1.01M in Q4 2019. 249 funds tracked by Wall St. Rank hold CNMD as of Q4 2020.

  • Aperio Group held 7,482 shares of CONMED worth $838K as of Q4 2020.
  • Aperio Group bought 297 CONMED shares in Q4 2020, an estimated $28.1K.
  • CONMED made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1691 holding.
  • Aperio Group first reported a position in CONMED in Q2 2015 and has held it in 21 quarters since.
  • Aperio Group's CONMED position peaked at $1.01M in Q4 2019.
  • 249 funds tracked by Wall St. Rank held CONMED as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.